highest dose glp 1 FDA greenlights higher-dose GLP-1 obesity shots what is the highest dosage
Description
Whats Next: Regulatory filing for weight management: by end of 2025 Submission for type 2 diabetes: expected in 2026 Drug discovered by Chugai, licensed by Lilly in 2018 Implication: Orforglipron could become the first once-daily oral GLP-1 therapy with potent glucose-lowering and weight-loss benefits, potentially disrupting the injectable incretin market.
Ramracheya, R
Both skipping the in-person visit
doi: 10.1056/NEJMoa2410027
